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Abstract
The optic nerve is morphologically classified as a peripheral nerve, but histologically it shares characteristics with 
the central nerves. Diseases that affect vision and the optic nerve are many and varied: optic neuritis, demyelination 
(multiple sclerosis, acute disseminated encephalomyelitis, neuromyelitis optica spectrum disorder, and myelin oligo-
dendrocyte glycoprotein antibody-related disorders), drugs, collagen disease, vasculitis, infection, trauma, vascular 
abnormalities, tumours, and non-tumoural masses. In this review, we summarise the magnetic resonance imaging 
findings for various pathological conditions that cause deterioration in visual acuity. 
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Introduction
The optic nerve is a relatively small structure, with a to-
tal length of 50 mm, but there are numerous causes of 
optic nerve disorders, including: inflammation, tumours, 
vascular disorders, metabolic diseases, infections, drugs, 
systemic diseases, genetic diseases, and trauma (Table 1). 
The frequency of each disorder is relatively low, and it is 
difficult to differentiate between them in daily practice. 
Magnetic resonance imaging (MRI) is a common diagnos-
tic imaging method for optic nerve disorders. However, 
abnormal findings for the optic nerve on MRI are similar 
and nonspecific for these diseases. Optic nerve enlarge-
ment with high signal intensity on T2-weighted images 
and contrast effect in the optic nerve are the main findings 
with optic nerve abnormalities. It is necessary to distin-
guish between abnormal findings around the optic nerve 
and clinical findings to differentiate these diseases [1,2]. 
In this paper, we review the imaging findings and clini-
cal background of various diseases that cause optic nerve 
abnormalities. 
Anatomy
The optic nerve is commonly divided into four parts: in-
traocular, intraorbital, optic canal, and intracranial. In the 
orbit, the optic nerve is surrounded by meninges called 
the optic nerve sheath, which extends from the intracrani-
al meninges to the eye. Cerebrospinal fluid exists between 
the optic nerve sheath and the optic nerve and is contin-
uous with the intracranial arachnoid space [2]. The blood 
supply of the optic nerve comes mainly from the central 
retinal artery, which is a branch of the ophthalmic artery. 
The central retinal artery enters the optic nerve approxi-
mately 1 cm behind the eye [1,2]. 
Magnetic resonance imaging protocols
Magnetic resonance imaging protocols for optic nerve 
evaluation vary from report to report, and there is no sin-
gle definitive protocol. Axial and coronal T1-weighted im-
ages without fat suppression, axial and coronal short-T1 
inversion recovery (STIR) images, and axial and coronal 
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post-contrast fat-suppressed T1-weighted images are com-
mon clinical MRI protocols for the optic nerve. MRI mag-
netic field strength of 1.5 T or 3 T is recommended, and 
the slice thickness should be less than 3 mm. The orbit 
and cavernous sinus should be included in both axial and 
coronal images [2].
Idiopathic optic neuritis
Idiopathic optic neuritis is an inflammation of the optic 
nerve of unknown cause. Idiopathic optic neuritis com-
monly affects women in their 20s or 30s. Typically, pa-
tients experience acute unilateral optic neuritis, resulting 
in vision loss and pain. Diagnosis of idiopathic optic neu-
ritis requires the exclusion of demyelinating diseases such 
as multiple sclerosis (MS), neuromyelitis optica spectrum 
disorders (NMO-SD), and myelin oligodendrocyte gly-
coprotein antibody (MOG-Ab)-associated optic neurop-
athy [3]. Even if a diagnosis of idiopathic optic neuritis 
is made, patients often develop MS, especially in cases in 
which abnormalities are detected on brain MRI. In pa-
tients with optic neuritis, orbital MRI for the evaluation of 
Table 1. Differential diagnosis of optic nerve disorders
Optic neuritis
Idiopathic optic neuritis 
Demyelinating disease
MS, ADEM, NMO-SD, MOG-Ab 
Hereditary optic neuropathy
Leber optic neuropathy
Autosomal dominant optic atrophy
Nutritional optic neuropathy
Vitamin B12 (cobalamin), vitamin B1 (thiamin), vitamin B2 (riboflavin), folic acid
Toxic optic neuritis
Methanol, carbon monoxide, ethylene glycol, perchloroethylene, tobacco, toluene, styrene, ethambutol, isoniazid, chloramphenicol, 
diaminodiphenyl sulphone, linezolid, cyclosporine, tacrolimus, α interferon-2b, 5-fluorouracil, cisplatin, carboplatin, nitrosoureas, paclitaxel, 
vincristine, amiodarone, chlorpropamide, benoxaprofen, cimetidine, disulfiram, melatonin, sertraline hydrochloride, deferoxamine, vigabatrin, 
sildenafil, TNF-α inhibitors 
Radiation-induced optic neuritis
Ischemic optic neuropathy
Arteritic (mostly giant cell vasculitis) ischemic optic neuropathy
Non-arteritic ischemic optic neuropathy
Collagen vascular disease
Behçet’s disease, systemic lupus erythematosus, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis 
Inflammatory mass
IgG4-related disease, sarcoidosis, inflammatory pseudotumor, Erdheim-Chester disease
Infection
Paranasal sinusitis (bacterial, mycotic), tuberculosis 
Traumatic injury
Vascular abnormalities 
Carotid-cavernous fistula, optic nerve sheath dural arteriovenous fistula, superior ophthalmic vein thrombosis
Optic nerve and optic nerve sheath tumour
Optic glioma, meningioma
Orbital tumour (especially orbital apex)
Lymphoma, cavernous haemangioma, schwannoma, invasion of paranasal sinus
 Malignancies, metastatic tumour
Compressive optic neuropathy 
Mucocele, dysthyroid optic neuropathy (thyroid-associated optic neuropathy)
TNF-α – antitumour necrosis factor α, MS – multiple sclerosis, ADEM – acute disseminated encephalomyelitis, NMO-SD – neuromyelitis optica spectrum disorder, MOG-Ab – myelin oligoden-
drocyte glycoprotein antibody, IgG4 – immunoglobulin G4 
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optic neuritis and brain MRI for the negation of demyeli-
nating disease are usually performed [4]. Idiopathic optic 
neuritis is evaluated by MRI, but the findings are non-spe-
cific. In the acute phase, the optic nerve is enlarged with 
high-intensity signal on T2-weighted or STIR images 
and has a contrast effect on post-contrast-enhanced 
T1-weighted image (Figure 1). On diffusion-weighted 
images, the optic nerve shows high signal with decreasing 
ADC value. In the chronic phase, the optic nerve is atro-
phied, with high-intensity signal on T2-weighted images, 
low-intensity signal on diffusion-weighted images, and 
poor contrast effect on post-contrast images [5]. 
Demyelinating disease
Acute disseminated encephalomyelitis (ADEM), MS, and 
NMO-SD are known inflammatory demyelinating diseas-
es that cause optic neuritis. These disease names are het-
erogeneous in nature and the diseases are best viewed as 
‘syndromes’ rather than specific disorders. In recent years, 
the detection of aquaporin-4 antibodies (AQP4-Ab) and 
MOG-Ab, which are the causative antibodies of inflam-
matory demyelinating disease, has been used for diag-
nosis, and the diagnosis of inflammatory demyelinating 
diseases is changing drastically [6-9]. 
ADEM is an inflammatory demyelinating disease that 
is common in children and is thought to be an immune 
system dysregulation triggered by an infection or vaccine 
administration. Preinfection exists in 72-77% of patients 
with ADEM about one week before onset, and ADEM de-
velops with symptoms such as: fever, headache, vomiting, 
visual abnormality, consciousness disturbance, and enceph-
alitis. ADEM is usually monophasic, but when it recurs, it 
is classified as polymorphic ADEM, MS, or NMO-SD [9]. 
On brain MRI, a high- signal area on T2-weighted images 
is primarily observed in the subcortical white matter and 
is partially accompanied by a contrast effect. An abnormal 
signal is also found on the optic nerve, but it is indistin-
guishable from other types of optic neuritis (Figure 2) [10]. 
Multiple sclerosis is a disease that causes demyelina-
tion in the brain, spinal cord, and optic nerve, and it re-
peats cycles of relapse and remission during its course. 
MS often accompanies optic neuritis and is an important 
differential diagnosis from optic neuritis. MS is prevalent 
among women in their 20s to 30s and, unlike ADEM, it 
rarely develops before puberty [11]. MS is diagnosed by 
clinical and MRI findings according to the McDonald 
criteria, but the image findings of optic neuritis are not 
included in the McDonald criteria. Optic nerve lesions 
in patients with MS show a high signal on T2-weighted 
images and have a contrast effect, but the lesions cannot 
be distinguished from other types of optic neuritis. In 
brain MRI, a high-signal area is observed in T2-weighted 
images, mainly around the periventricular white matter. 
Patients who develop optic neuritis should undergo brain 
MRI to exclude MS [12].
Neuromyelitis optica spectrum disorders, which are 
characterised by a positive test for AQP4-Ab, forms de-
myelinating lesions in the optic nerve and spinal cord. 
Previously, NMO-SD was regarded as a subtype of MS, 
but it was reclassified as an independent disease due to the 
discovery of AQP4-Ab. NMO-SD typically develops in 
women in their late 30s, with symptoms of transverse my-
elitis and bilateral optic neuritis. Diagnosis of NMO-SD is 
based mainly on AQP4-Ab, MRI, and clinical findings [8]. 
The optic nerve lesion in NMO-SD, like MS, is nonspecific 
on MRI (Figure 3), but exists for longer than that in MS [13]. 
On brain MRI, high signal on T2-weighted images is seen 
mainly in the dorsal side of the medulla, the fourth ven-
tricle peripheries, the thalamus, and the hypothalamus, 
where the expression of AQP4 is high [14]. 
In recent years, MOG-Ab has also been found to cause 
demyelination in the central nervous system. Although 
MOG-Ab was first reported as a cause of AQP4-negative 
Figure 1. Idiopathic optic neuritis. The left optic nerve has high signal intensity on the STIR image (A) and is enhanced on the fat-suppressed contrast 
T1-weighted image (B)
A B
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NMO-SD, MOG-Ab is also detected in patients diagnosed 
with idiopathic optic neuritis or ADEM [15]. Like other MRI 
findings in optic neuritis, the optic nerve lesion in MOG-
Ab shows high-intensity signal on T2-weighted images with 
a contrast effect. The MOG-Ab-positive optic nerve lesion 
develops in the relatively anterior part of the optic nerve, 
whereas the AQP4-Ab-positive forms more posteriorly in 
the optic nerve. A contrast effect spreading around the optic 
nerve sheath is more suggestive of an MOG-Ab positive op-
tic nerve lesion than an optic nerve lesion due to MS or an 
AQP4-Ab-positive optic nerve lesion (Figure 4) [16]. 
Hereditary optic neuropathy
Leber hereditary optic neuropathy and autosomal dom-
inant optic atrophy are well-known hereditary neuropa-
Figure 2. Optic neuritis due to acute disseminated encephalomyelitis. 
There are high-signal areas in the subcortical white matter on the right in 
the FLAIR image (A). The chiasm is enlarged with high signal intensity on 





Figure 3. Optic neuritis due to neuromyelitis optica spectrum disorders. The left optic nerve shows a high signal and is swollen on the STIR image (A), and 
is enhanced on the fat-suppressed contrast T1-weighted image (B)
A B
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Figure 5. Radiation-induced optic neuritis. There is faint high signal intensity in the optic nerve, and the optic nerve sheath signal is lower than the sur-
rounding tissue on the STIR image (A). The optic nerve is enhanced on the post-contrast, T1-weighted image (B)
A B
Figure 4. Myelin oligodendrocyte glycoprotein antibody-positive optic 
neuropathy. Bilateral optic nerves and fat tissue around the left optic nerve 
sheath (yellow arrow) are enhanced on the post-contrast, fat-suppressed, 
T1-weighted image
thies, but other hereditary optic neuropathies, such as 
congenital recessive optic atrophy, apparent sex-linked 
optic atrophy, and autosomal recessive chiasmal optic 
neuropathy, are all extremely rare [17].
Leber hereditary optic neuropathy is a maternally in-
herited disorder caused by a mitochondrial abnormality. 
Leber hereditary optic neuropathy typically affects men, 
|and patients usually develop subacute, progressive vision 
loss in their teens or 20s. Initially, the loss of vision is unilat-
eral, but after several months vision in the contralateral eye 
also decreases. Unlike other types of optic neuritis, Leber he-
reditary optic neuropathy in its acute phase does not cause 
any abnormality on orbital MRI. However, in the chronic 
phase, the posterior optic nerve and optic chiasm enlarge 
with hyperintense signal on T2-weighted images [18]. 
Nutritional optic neuropathy
Nutritional optic neuropathy is a condition that causes bi-
lateral loss of visual acuity due to nutrient deficiency. Nu-
tritional optic neuropathy is rarely present in developed 
countries but may develop in individuals with extreme 
weight loss or an extremely unbalanced diet. Deficiency of 
vitamin B12 (cobalamin), vitamin B1 (thiamin), vitamin B2 
(riboflavin), or folic acid can cause nutritional optic neu-
ritis. Nutritional optic neuropathy is diagnosed based on 
a lack of nutrients in the blood. There are a few reports 
that MRI is useful in diagnosing nutritional optic neuropa-
thy [19]. In patients with vitamin B1 deficiency (Wernicke’s 
encephalopathy), a high-signal area appears in the cerebral 
aqueduct, inside the thalamus, midbrain, and mammillary 
body, so brain MRI may be useful for diagnosis [20]. 
Toxic optic neuritis
Toxic optic neuritis is a neuropathy caused by the inges-
tion of toxic substances or by side effects of drugs. Numer-
ous toxins and drugs are associated with optic neuritis. 
The mechanisms of optic nerve toxicity vary depending 
on the agent. Bilateral loss of vision is a typical symptom, 
and other neurological complaints may be present in 
some cases. Since most image findings of toxic optic neu-
ritis are nonspecific, like other forms of optic neuritis, or 
are unknown, orbital MRI is performed to exclude other 
diseases that cause optic neuritis [21,22]. 
Radiation-induced optic neuritis
Radiation-induced optic neuritis is an essential complica-
tion of radiation therapy involving the anterior visual path-
way; this neuritis can occur with a total dose of ≥ 50 Gy or 
a single dose of ≥ 10 Gy. Radiation-induced optic neuritis 
typically causes sudden unilateral vision impairment at 
around one year after radiotherapy, but occasionally oc-
curs after three years. Within months after vision loss, the 
optic nerve in the irradiated area displays iso- or hyper-
Tomonori Kanda, Aki Miyazaki, Feibi Zeng et al.  
e72 © Pol J Radiol 2020; 85: e67-e81
intensity on T2-weighted images, and contrast effect on 
T1-weighted images (Figure 5), but the contrast effect 
disappears within a few months [23].
Ischaemic optic neuropathy
Ischaemic optic neuropathy is the most common cause of 
unilateral optic neuropathy in patients over age 50 years. 
Ischaemic optic neuropathy is caused not by inflamma-
tion, but by impaired blood flow to the optic nerve. Is-
chaemic optic neuropathy is classified as either arteritic 
(mostly giant cell vasculitis) or non-arteritic (in which 
a shortage of blood flow to the optic nerve is suspected). 
Non-arteritic ischaemic optic neuropathy results from 
disease of the small vessels, but its exact cause remains 
unknown. The most common systemic disorders associ-
ated with non-arteritic ischaemic optic neuropathy are 
hypertension and diabetes mellitus. 
Ischaemic optic neuropathy can be further classified 
into an anterior form, involving the papilla, and a pos-
terior form, which does not involve the papilla. Anterior 
ischaemic optic neuropathy is diagnosed based on the 
presence of papilledema, but posterior ischaemic optic 
neuropathy is usually diagnosed by excluding diagnoses 
of other kinds of optic neuropathy, because it does not 
involve papilloedema [24]. 
MRI is useful for evaluating arteritic ischaemic optic 
neuropathy due to giant-cell arteritis. The optic neuropa-
thy can be detected with minute contrast effects in the op-
tic nerve by using enhanced black-blood 3D T1-weighted 
images [25]. In addition, MRI can be effectively used to 
diagnose temporal arteritis, by visualising wall thickening 
and contrast effect of the temporal artery [26]. Conversely, 
MRI is less useful in diagnosing non-arteritic ischaemic 
optic neuropathy because MRI can scarcely depict the op-
tic nerve abnormalities. The main role of MRI in non-ar-
teritic ischaemic optic neuropathy is to exclude other 
types of optic neuropathy [27]. 
Collagen vascular disease
Several collagen vascular diseases cause vasculitis in blood 
vessels of the optic nerve, resulting in visual impairment. 
Giant-cell vasculitis is the most common collagen vas-
cular disease-causing optic neuritis, but Behçet’s disease, 
systemic lupus erythematosus (SLE), granulomatosis with 
polyangiitis (GPA), and eosinophilic granulomatosis with 
polyangiitis (EGPA) can also cause optic neuritis [28]. 
Behcet’s disease is a chronic, recurrent systemic in-
flammatory disease, in which the main symptoms are oral 
aphthae, vulva ulcers, skin lesions, and retinal choroiditis. 
In the eye, Behcet’s disease typically involves uveitis, but 
sometimes it affects the optic nerve. In MRI, enlargement 
of the optic nerve with high-intensity signal on STIR im-
aging and contrast effect around the optic nerve sheath 
(the so-called sunflower-like sign) is typical [29]. 
SLE is a chronic autoimmune disease that can affect 
multiple organ systems. Optic neuritis develops in about 
1% of SLE patients and is usually accompanied by painful 
unilateral vision loss. The cause of optic neuritis is the 
autoimmunity by AQP4-Ab and ischaemia due to vascu-
litis. MRI shows optic nerve enlargement with contrast 
effect [30].
GPA is a type of necrotic, granulomatous vasculitis 
that spreads throughout the body, mainly in the upper 
respiratory tract and lungs; it is related to the antineutro-
phil cytoplasmic antibodies. Orbital involvement is com-
mon in GPA patients, occurring in approximately 50% of 
cases, and causes visual impairment due to intraorbital 
granuloma formation and scleritis. The intraorbital mass 
of GPA shows low signal intensity on T2-weighted imag-
es and is enhanced heterogeneously. GPA often accompa-
nies sinus-wall thickening, and nasal-septal perforation 
also occurs (Figure 6) [31]. GPA also causes hypertrophic 
pachymeningitis, but it may progress to the optic nerve 
sheath and cause optic neuritis. MRI shows contrast ef-
fect on the thickened dura and the optic nerve sheath on 
the affected side, and a high-signal area exists in the optic 
nerve on T2-weighted images [32]. 
Eosinophilic granulomatosis with polyangiitis is de-
fined as a systemic, necrotising small-vessel vasculitis, 
associated with asthma and with blood and tissue eosin-
ophilia. EGPA often develops in the peripheral nerves, 
but sometimes it progresses to the central nervous sys-
tem and the optic nerve. Patients with EGPA often suffer 
from optic neuritis or obstruction of the central retinal 
artery, resulting in impaired vision. MRI shows high-sig-
nal intensity in the orbit on STIR images in EGPA patients 
(Figure 7) [33]. 
Inflammatory disease
A variety of inflammatory or inflammation-like tumour 
masses can form in the orbit, all of which cause a decrease 
in visual acuity. Such known tumour masses include im-
munoglobulin G4 (IgG4)-related disease, sarcoi dosis, 
Erdheim-Chester disease, and inflammatory pseudo-
tumour. 
IgG4-related diseases are chronic inflammatory dis-
eases in which blood IgG4 is elevated, forming a tumour 
that causes IgG4-positive plasma cells to infiltrate various 
organs. IgG4-related diseases are diagnosed according 
to imaging findings, elevated blood IgG4, and patholog-
ical findings. The orbital MRI findings in IgG4-related 
diseases are swelling of the lacrimal gland, intraorbital 
mass, enlargement of the extraocular muscle(s), and en-
largement of cranial nerves, such as the suborbital nerve. 
Hypertrophic meningitis sometimes affects patients with 
IgG4 diseases, and it can spread to the optic nerve sheath 
(Figure 8). When IgG4-related hypertrophic meningitis in 
the optic nerve sheath presses on the optic nerve, visual 
function can be reduced [34].
 Magnetic resonance imaging of intraocular optic nerve disorders: review article 
e73© Pol J Radiol 2020; 85: e67-e81
Sarcoidosis is an inflammatory disease of unknown 
cause, which occurs in multiple organs. Uveitis and ret-
initis are frequent manifestation of sarcoidosis, but op-
tic nerve lesions are uncommon. However, in cases of 
neurosarcoidosis, cranial nerve involvement is the most 
common presenting feature (55%), with the optic nerve 
being most commonly affected (33-75%). Optic nerve 
sarcoidosis usually occurs unilaterally, but it develops bi-
laterally in 31% of patients. With orbital MRI, the optic 
nerve shows a high signal on T2-weighted images, and 
contrast effect exists in the optic nerve and optic nerve 
sheath [35].
Erdheim-Chester disease is a rare non-Langerhans 
cell histiocytosis that is characterised by xanthomatous 
infiltration of tissues. Patients with Erdheim-Chester dis-
ease usually develop limb-bone pain in their 40s or 50s. 
Erdheim-Chester disease is characterised by bilateral 
and symmetric osteosclerosis of the diaphysis of the long 
Figure 6. Granulomatosis with polyangiitis. On the T1-weighted image (A), 
a low-signal mass is visible in the left orbit (yellow arrow), and a heterogene-
ous-signal mass is visible in the ethmoid sinus (green arrowhead). The high 
T1 signal in the paranasal sinus reflects the exudate with micro-bleeding. 
On the STIR image (B), the left orbital tumour (yellow arrow) and ethmoid 
sinus (green arrowhead) show a mixture of low- and high-intensity signal. 
On the T1-weighted image (C), there is a nasal septum defect (*). Sinusitis 





Figure 7. Eosinophilic granulomatosis with polyangiitis. A high signal is observed on both eyelids (yellow arrow) and orbits on the STIR image (A), and there 
is heterogeneous contrast effect in the eyelids (yellow arrow) and orbits (green arrowheads) on fat-suppressed contrast T1-weighted image (B)
A B
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Figure 8. IgG4-related disorders. Two cases of IgG4-related disease are shown. Bilateral lacrimal glands (red arrows) and infraorbital nerves (yellow arrows) 
are enlarged due to the IgG4-related disease on the contrast-enhanced coronal T1-weighted image (A). The dura (yellow arrows) and the bilateral optic nerve 
sheaths (red arrows) have been thickened and contrast-enhanced due to the hypertrophic meningitis on the contrast-enhanced, T1-weighted image (B)
Figure 9. Erdheim-Chester disease. There is a low-signal-intensity mass in the bilateral orbital fat around the optic nerve on the T1-weighted image (A). 





bones on X-ray. The orbital lesions mainly show low- 
intensity signal on both T1- and T2-weighted images, and 
diffuse enhancement in post-contrast T1-weighted images 
(Figure 9). Although the mass pressures the optic nerve, 
vision deterioration is rare [36].
Inflammatory pseudotumour is a non-infectious in-
flammatory mass, without systemic disease, and is the 
most common type among painful orbital mass. The cause 
of inflammatory pseudotumour is unknown, and the diag-
nosis is made by exclusion, based on clinical and imaging 
findings. The symptoms differ depending on the lesion site, 
but when it is close to the optic nerve, it causes a decrease 
in visual function. Inflammatory pseudotumour occurs 
around the lacrimal gland, extraocular muscle peripher-
ies, optic nerve sheath circumference, orbital apex, and 
so on. Inflammatory pseudotumours show low-intensity 
signal on both T1-and T2-weighted images with orbital 
MRI (Figure 10) [37]. 
Infection
A variety of bacterial infections, fungal infections, and vi-
ral infections can occur in the orbit. When inflammation 
due to infection reaches the optic nerve, visual function 
deteriorates. Orbital infections usually originate from si-
nusitis, especially from the ethmoid sinuses, leading to 
orbital bacterial or fungal infections. Bacterial infections 
of the orbit are common in healthy individuals. MRIs of 
patients with bacterial sinusitis-induced optic neuritis 
show paranasal sinuses and orbital fat with low signals on 
T1-weighted images; high signals appear on fat-suppres-
sion T2-weighted images. The optic nerve is surround-
ed by the mass and presents a high-intensity signal on 
T2-weighted images (Figure 11) [38]. 
Fungal sinusitis is histologically divided into invasive 
and non-invasive forms. Invasive sinusitis is rare and likely 
to occur in immunocompromised patients. Fungal optic 
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Figure 11. Optic neuritis due to bacterial sinusitis. The mucosa of the right ethmoid sinus is thickened (green arrowheads) with high-intensity signal, and 
the right orbital fat and the optic nerve (yellow arrow) show high signal intensity. On fat-suppressed contrast T1-weighted image (B), the right ethmoid 
sinus (green arrowheads) and orbit (yellow arrow) are heterogeneously enhanced
Figure 10. Inflammatory pseudotumour. A low-signal mass with unclear 
boundary (yellow arrows) is visible around the left internal rectus muscle on 
the T1-weighted image (A). The mass also has low signal on the STIR image (B) 





neuritis is caused by invasive sinusitis and is similar to its 
bacterial counterpart, but sinus-wall thickening and orbit-
al lesions are often limited. Furthermore, fungal infections 
of the paranasal sinuses and orbits show low signals in 
T2-weighted images and become obscure in fat-suppressed, 
T2-weighted images on MRI. In cases of optic neuritis due 
to fungal sinusitis, attention should be paid to the abnor-
mality of the fat signal at the orbital apex (Figure 12) [39]. 
Tuberculous optic neuritis occurs as tuberculous 
meningitis develops in the optic nerve and optic chiasm. 
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Figure 12. Invasive aspergillosis of the orbital apex. The orbital apex has 
low signal (green arrows), and the mucosa of the ethmoid sinus is mildly 
thickened on the STIR image (A). The fat tissue of the orbital apex (green 
arrows) has low signal intensity compared with the contralateral side on the 
T1-weighted image (B). It is difficult to detect the lesion on the post-con-




In addition to the presence of meningitis, the ring-shaped 
contrast effect and swelling are recognisable in the optic 
nerve in cases of tuberculous optic neuritis. Brain MRI vis-
ualises hydrocephalus, meningeal hyperplasia, and tuber-
culoma, which are findings of tuberculous meningitis [40]. 
The optic nerve can also be affected by various infec-
tious diseases such as Bartonella, cytomegalovirus, Ep-
stein-Barr virus, human immunodeficiency virus, Lyme 
disease, syphilis, toxoplasmosis, toxocariasis, and varicella 
zoster virus, but there are no comprehensive reports about 
MRI findings in optic neuritis due to these infections [14].
Traumatic optic neuropathy
Traumatic optic neuropathy is a complication of head and 
orbit trauma, and can be divided into direct injury and in-
direct injury cases. Indirect injury is more common than 
direct injury, and the incidence of traumatic optic neu-
ropathy is estimated to be 0.5-5% in cases of head trau-
ma. Optic neuropathy due to indirect injury is a traumatic 
visual disorder with no abnormality in the optic nerve, 
diagnosed with ophthalmoscopic and image analysis such 
as CT and MRI. However, in optic neuropathy due to di-
rect injury, image analysis can visualise bone fragments 
and foreign bodies that damage the optic nerve. CT is the 
first test method for traumatic optic neuropathy because 
it can evaluate the whole body at the same time and can 
depict most foreign bodies and bone fragments. MRI can 
visualise optic nerve damage as a high-intensity signal on 
T2-weighted images, but only plays a small role in diag-
nosing traumatic optic neuropathy [41].
Vascular abnormalities 
Carotid cavernous fistula (CCF) is an abnormal commu-
nication between the carotid artery and vein in the cav-
ernous sinus, due to trauma or the rupture of an aneu-
rysm. Symptoms of CCF include ocular prolapse, red eye, 
bruit, and double vision, but visual acuity reduction due 
to high venous pressure also occurs. MRI findings from 
a CCF show no abnormality in the optic nerve, but they 
are often accompanied by dilation of the superior ocular 
vein and cavernous sinus (Figure 13). MR angiography is 
also used for diagnosis of CCF, but exclusion diagnosis 
of CCF is difficult when only using MRA, due to poor 
sensitivity. The diagnosis of CCF is usually based on an-
giography or CT angiography [42]. 
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Figure 13. Carotid cavernous fistula. Dilation of the superior ophthalmic 
vein (arrows) on this T2-weighted image is a finding that casts doubt on 
the carotid cavernous fistula
Figure 14. Superior ophthalmic vein thrombus. The right superior ophthal-
mic vein (yellow arrows) is dilated on the T1-weighted image (A), and the 
lumen has high signal intensity on the STIR image (B) without contrast 
effect on the post-contrast, T1-weighted image (C)
Superior ophthalmic vein thrombosis is a very rare 
disorder, which is caused by orbital infections and var-
ious kinds of inflammation. The superior ophthalmic 
vein is responsible for most of the venous perfusion of 
the orbit, and superior ophthalmic vein thrombosis caus-
es protrusion of the eye, a decrease in visual acuity, and 
limitations of eye movements. Superior ophthalmic vein 
thrombus presents an enlarged superior ophthalmic vein 
with a high-intensity signal in the lumen on T2-weighted 
images. The vein wall is thickened with a contrast effect, 
but there is no contrast effect in the lumen (Figure 14). 
Cavernous sinus thrombosis is often accompanied by su-
perior ophthalmic vein thrombosis [43].
Optic nerve and optic nerve sheath neoplasm
Of tumours arising from the optic nerve or optic nerve 
sheath, optic gliomas and meningiomas are common 
[44]. Optic gliomas are the most common tumours of 
optic nerve origin. Optic gliomas are common in chil-
dren under the age of eight years, and most can be clas-
sified as juvenile pilocytic astrocytomas. Optic gliomas 
are often associated with neurofibromatosis type 1 (NF1) 
and are found in 20% of NF1 cases. Sporadic optic glio-
mas are more likely to be localised to the optic chiasm 
and are more symptomatic than NF1-associated optic 
gliomas. MRI can visualise the enlargement of the optic 
nerve and show a high signal on T2-weighted images, 
but the contrast effect of the tumour varies. There may 
be a high-signal area at the periphery of the tumour on 
T2-weighted images, which is highly suggestive of optic 
glioma [44,45]. 
Optic nerve sheath meningioma is a type of meningi-
oma that spreads along the meninges of the optic nerve 
sheath. Ninety per cent of optic nerve sheath meningi-
omas develop from the intracranial meninges, with only 
10% originating from the optic nerve sheath. Because 
the optic nerve sheath is narrow, most optic nerve sheath 
meningiomas compromise visual function. MRI displays 
a soft-tissue mass along the optic nerve sheath, and the 
contrast effect along the optic nerve sheath can be rec-
ognised on post-contrast-enhanced, T1-weighted images. 
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Figure 15. Optic nerve sheath meningioma. The optic nerve sheath is thick-
ened with a contrast effect on this post-contrast T1-weighted image. This 
double-line contrast effect is the so-called tram-track sign
contrast-enhanced, axial T1-weighted images are called 
the “tram-track sign” (Figure 15), but this finding is not 
specific to optic nerve meningiomas because it is also 
found in cases of optic perineuritis. CT aids in diagnoses 
by depicting calcification in the tumour [44]. 
Orbital tumour
The optic nerve is compressed by various tumours, 
which results in visual function reduction, particularly 
with tumours at the orbital apex. Tumours that compress 
the optic nerve include primary orbital tumours, direct 
tumour invasion from an adjacent structure, and met-
astatic orbital tumours. Of orbital tumours, lymphoma, 
cavernous haemangiomas, and schwannomas frequently 
occur, and, even if they are benign, they press on the op-
tic nerve [44]. 
Lymphoma is the most frequently occurring of intra 
orbital tumours and is common in people over the age of 
60 years. On MRI, lymphoma is often seen as an ill-de-
fined mass, but sometimes it is a smooth, circumscribed 
mass. Lymphoma may spread along the existing structures, 
such as the optic nerve, and this finding is characteristic of 
lymphoma (Figure 16) [46]. Cavernous haemangiomas are 
not true tumours but are the most common orbital mass-
es in adults. On MRI, cavernous haemangioma presents 
a smooth border with hyperintensity on T2-weighted im-
ages. Visual abnormalities due to cavernous haemangio-
mas are rare, but they can cause compressive optic neuritis 
at the orbital apex. Schwannomas are rare in the orbit, but 
they arise from the trigeminal, oculomotor, trochlear, and 
abducens nerves. On MRI, a schwannoma is a well-defined 
mass that develops along the nerve. A schwannoma is 
a mixture of components of Antoni A areas, characterised 
by rich cellular areas, and Antoni B areas, characterised 
by poor cellular areas, and it exhibits a complicated sig-
Figure 16. Lymphoma. An ill-defined low-signal mass (yellow arrows) is 
located around the left optic nerve on the T1-weighted image (A). The mass 
has low signal on the STIR image (B) and contrast effect on the post-con-
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Figure 17. Schwannomas of the oculomotor nerve. A dumbbell-shaped tumour exists from the cavernous sinus to the orbit (yellow arrows). The tumour 
periphery has high signal intensity, and the interior is iso-intense with the brain on the STIR image (A). The inside of the tumour is enhanced on the 
post-contrast, fat-suppressed, T1-weighted image (B) 
A B
nal on T2-weighted images (Figure 17). Although visual 
performance rarely deteriorates, it can if the optic nerve is 
compressed [44].
Paranasal malignancies are commonly accompanied 
orbital invasion. In many cases, the infiltration of the si-
nus by malignant tumours remains in the orbital perios-
teum, and it is rare that an optic nerve injury occurs at the 
beginning. However, local recurrence of the tumour often 
invades the optic nerve [47]. 
Metastatic tumours account for 1-13% of orbital tu-
mours, and 16-23% of patients develop vision loss. Breast 
cancer, lung cancer, and prostate cancer are common sourc-
es of orbital metastases, but their frequency differs depend-
ing on the demographics and country of origin of the study. 
The image findings of metastatic tumours are nonspecific 
except for forming mass in the orbit (Figure 18), and the 
history of malignant tumours is important [48].
Compressive optic neuropathy 
Compressive optic neuritis is a form of neuritis that oc-
curs when the optic nerve is compressed by a mass. This 
section deals with compression that is not caused by tu-
mours or inflammatory masses.
A mucocele is not a tumour, but it forms encapsulated 
mucous cavities in the paranasal sinuses. As the mucocele 
increases, it progresses to the orbit and compresses the op-
tic nerve. When the mucocele occurs in the Onodi cell sur-
rounding the optic nerve, or the anterior floor processes, it 
is close to the optic nerve and often causes acute vision loss. 
A mucocele is a smooth-margin mass that causes bulging 
in the surrounding bone, and in many cases it is easy to 
distinguish from malignant paranasal sinus tumours. On 
MRI, a mucocele presents high-intensity signals in both 
T1-weighted images and T2-weighted images without con-
A B
Figure 18. Optic canal metastasis from breast cancer. The right orbital apex has low signal (yellow arrows) compared with the contralateral side on the 
T1-weighted image (A). The right orbital apex is heterogeneously enhanced (yellow arrows) compared with the contralateral side on the fat-suppressed, 
post-contrast, T1-weighted image (B). As a result of the whole-body assessment, the tumour was diagnosed as an optic canal metastasis from the patient’s 
breast cancer
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trast effect due to fluid containing a high level of protein 
(Figure 19) [49]. 
Thyroid ophthalmopathy is an orbital condition that 
has a strong association with thyroid autoimmune diseas-
es, particularly Graves’ disease. Dysthyroid optic neurop-
athy is the most severe form of thyroid ophthalmopathy, 
and the optic nerve is compressed by the enlarged ex-
traocular muscles, resulting in visual impairment. Dys-
thyroid optic neuropathy is relatively rare and accounts 
for less than 5% of thyroid ophthalmopathy cases in most 
studies. MRI can show optic nerve compression by swol-
len extraocular muscles, and it can demonstrate inflam-
mation of extraocular muscles and orbital fat tissue with 
high-intensity signal on STIR images. The optic nerve in 
dysthyroid optic neuropathy is almost normal on con-
ventional MRI. Attempts have been made to detect nar-
rowing of the optic nerve diameter, using high-resolution 
T1-weighted images, but the results overlap with thyroid 
ophthalmopathy without visual impairment [50].
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